- Home
- ES vs WST Comparison
ES vs WST Comparison
Compare ES & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ES | WST |
|---|---|---|
| Founded | 1927 | 1923 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 18.5B |
| IPO Year | 1994 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ES | WST |
|---|---|---|
| Price | $68.71 | $320.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 7 |
| Target Price | $71.00 | ★ $325.86 |
| AVG Volume (30 Days) | ★ 2.1M | 681.9K |
| Earning Date | 05-06-2026 | 04-23-2026 |
| Dividend Yield | ★ 4.58% | 0.30% |
| EPS Growth | ★ 100.88 | 1.49 |
| EPS | 1.61 | ★ 1.92 |
| Revenue | ★ $13,547,244,000.00 | $2,886,900,000.00 |
| Revenue This Year | N/A | $6.76 |
| Revenue Next Year | $3.77 | $6.22 |
| P/E Ratio | ★ $43.01 | $167.40 |
| Revenue Growth | ★ 13.83 | 1.95 |
| 52 Week Low | $61.53 | $206.19 |
| 52 Week High | $76.41 | $330.88 |
Technical Indicators
Market Signals| Indicator | ES | WST |
|---|---|---|
| Relative Strength Index (RSI) | 48.12 | 65.15 |
| Support Level | $66.53 | $259.17 |
| Resistance Level | $68.84 | $324.52 |
| Average True Range (ATR) | 1.22 | 9.07 |
| MACD | 0.12 | -0.58 |
| Stochastic Oscillator | 49.08 | 71.63 |
Price Performance
Historical ComparisonAbout ES Eversource Energy (D/B/A)
Eversource Energy is a diversified holding company with subsidiaries that provide rate-regulated electric, gas, and water distribution service to more than 4 million customers in the Northeast US. Eversource expanded its service territories with acquisitions of NStar (2012), Aquarion (2017), and Columbia Gas (2020). In 2024 Eversource exited its 50% partnership with European utility Orsted to develop 2 gigawatts of offshore wind projects in the Northeast US. It plans to sell Aquarion in 2026. The company exited most of its unregulated businesses in 2006.
About WST West Pharmaceutical Services Inc.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.